Summary & Overview
HCPCS G8893: Most Recent LDL-C Not Under Control, Results Documented and Reviewed
HCPCS Level II code G8893 denotes documentation and clinician review of a patient’s most recent LDL-C result when that value is not under control. Nationally, this code signals attention to cardiovascular risk management and quality measurement around cholesterol control, informing payers and providers about gaps in lipid management and the need for care plan reassessment.
Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for use of the code, typical sites of service where the code is applied, and an overview of what documentation the code captures. The publication summarizes benchmark usage patterns, common billing considerations, and relevant policy or quality-measure updates when available. Where specific input data is missing, the text notes that data is not available in the input.
This summary is intended for a national audience of clinicians, billing professionals, and policy analysts seeking a concise explanation of the code’s purpose, operational context, and implications for quality measurement in LDL-C management.
Billing Code Overview
HCPCS Level II code G8893 indicates that the most recent LDL-C is not under control, and that the results have been documented and reviewed. This code reflects clinical assessment and documentation related to low-density lipoprotein cholesterol (LDL-C) management.
Service type: Clinical outcome assessment and documentation — the code is used to record review and documentation of uncontrolled LDL-C results.
Typical site of service: Outpatient clinical settings, including primary care clinics, cardiology or lipid clinics, and ambulatory care centers where laboratory results are reviewed and care plans are discussed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with established atherosclerotic cardiovascular disease attends a routine chronic disease management visit at a primary care clinic. The clinician reviews the patient’s most recent laboratory results and identifies that the most recent low-density lipoprotein cholesterol (LDL-C) value remains above the individualized treatment goal despite current statin therapy. The visit documentation includes the test date, numeric LDL-C result, and clinician review notes discussing adherence, potential medication intensification, lifestyle counseling already provided, and plans for follow-up laboratory monitoring. The clinical workflow includes verifying the lab result in the electronic health record, documenting review and clinical interpretation in the progress note, and coding the encounter with the HCPCS Level II code G8893 to indicate that the most recent LDL-C is not under control and results were documented and reviewed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |